26.05.2024, 706 Zeichen

Valneva: Valneva, a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024. Dr. Schuitemaker brings more than two decades of experience in vaccine discovery and development. She formerly served as Global Head of Viral Vaccine Discovery and Translational Medicine at Johnson & Johnson (J&J), with responsibility for the strategy and execution of vaccine programs on COVID-19, HIV, RSV, Ebola, and multiple other viral disease targets for almost 14 years.
Valneva: weekly performance: -5.37%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (20/05/2024)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1077: ATX etwas leichter, Wienerberger gesucht, ich spreche über End of an Era sowie auch den Start von etwas Neuem

Bildnachweis

Aktien auf dem Radar:Amag, Flughafen Wien, Polytec Group, Kapsch TrafficCom, Agrana, Rosenbauer, Palfinger, Porr, Addiko Bank, Austriacard Holdings AG, EuroTeleSites AG, Strabag, AT&S, Frequentis, Mayr-Melnhof, voestalpine, Wienerberger, BKS Bank Stamm, Oberbank AG Stamm, SW Umwelttechnik, Athos Immobilien, EVN, CPI Europe AG, OMV, Österreichische Post, Verbund.

---